Twist Bioscience (TWST) Total Non-Current Liabilities (2018 - 2025)

Twist Bioscience (TWST) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $181.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 19.06% to $181.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $181.2 million through Dec 2025, up 19.06% year-over-year, with the annual reading at $168.2 million for FY2025, 19.07% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $181.2 million at Twist Bioscience, up from $168.2 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $181.2 million in Q4 2025, with the low at -$13.3 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $138.3 million, with a median of $151.2 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities crashed 121.64% in 2021, then surged 1331.26% in 2022.
  • Over 5 years, Total Non-Current Liabilities stood at -$13.3 million in 2021, then soared by 1331.26% to $163.6 million in 2022, then fell by 13.01% to $142.3 million in 2023, then increased by 6.98% to $152.2 million in 2024, then grew by 19.06% to $181.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $181.2 million, $168.2 million, and $164.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.